Projects
This section presents pharmaceutical projects that are announced from time-to-time around the world.
Kaneka Eurogentec to Build Manufacturing Facility in Belgium
Introduction Kaneka Eurogentec announced plans to build a new large scale pharmaceutical grade biologics manufacturing facility in Seraing, Belgium Features A new state oftheart facility will be adjacent to its current facility and will produce proteinbased drugs, antibody fragments and plasmid DNA for therapeutics The construction of t...
Natco Pharma Plans to Expand its API facility in Tamil Nadu with US$1 Billion/Rs 100 Crore Investment
Introduction Hyderabadbased Natco Pharma is planning to expand its Active Pharmaceutical Ingredient API and intermediates manufacturing facility in Tamil Nadu with an investment of $1 BillionRs 100 Crore Features The company plans to invest in its existing facility in Thiruvallur District Natco Pharma is investing $1 BillionRs 100 Crore in...
Sterling Invests $8 Million to Expand its Million, Micronisation and Solid Form Capabilities
Introduction Sterling Pharma Solutions invests $8 Million into a new facility at its UK to strengthen and expand its milling, micronisation and solid form capabilities Features The contract development and manufacturing organization will meet growing demand for pharmaceutical API particle size control technology It will meet Sterlings l...
Merck Invests $41 Million in Its Italian Biotech Manufacturing Site of Bari
Introduction Merck will invest $41 million in a new production line for the aseptic filling of biotech medicines under isolator at its manufacturing site of Bari, Italy Features The new production is expected to be fully operational in 2022 and it will be equipped with an isolator designed with the latest technologies and with a high level...
Nitto Denko Avecia Announces Opening of Manufacturing Expansion in Milford, MA
Introduction Nitto Denko Avecia Inc Avecia announced the opening of its new oligonucleotide API active pharmaceutical ingredients manufacturing facility in Milford, MA Features The opening of the manufacturing facility will take place in 2017 onsite at the Milford, MA facility This expansion will help Avecias clients to receive timely o...
ImmunoPrecise Antibodies Announces New Antibody Production Laboratory at Vancouver Island Technology Park
Introduction ImmunoPrecise Antibodies announced the opening of its new 3,200 square foot state of the art antibody production laboratory at Vancouver Island technology Park Features The production laboratory has been designed in conjunction with Low Hammond Rowe Architects Architectural and engineering features enhance the workflow and cle...
Natco Pharma Plans $75 Million Expansion Project in Telangana, India
Introduction Natco Pharma plans to increase the production capacity and research development activity at Rangareddy plant in Telangana, India that would generate 1, 500 jobs Features Natco Pharma plans to increase the production capacity and research development activity at Rangareddy plant in Telangana The proposal is to increase the...
CARsgen Announces Opening of CAR-T Cell Manufacturing Facility in Shanghai
Introduction Shanghaibased CARsgen Therapeutics Carsgen announced the opening of CART cell manufacturing facility in Shanghai to support CARsgen clinical programs Features CART cell manufacturing facility is in strict compliance with current good manufacturing procedure cGMP regulations of China Food and Drug Administration CFDA The 33,...
Novasep Invests US$30 million to Build Viral Vector Production Facility
Introduction Novasep announced a strategic investment of US$30 million for a commercial scale production facility of viral vectors Features The new facility will be built at Novasep in Seneffe, Belgium to complement the existing labscale suites of the neighbouring site in Gosselies The site will feature two cGMP suites on 2000 sqm equip...
Sanofi and Lonza to Build New US$285 million Swiss Biologics Facility
Introduction Sanofi, French drugmaker and Swiss manufacturer Lonza will invest US$285 million to build a new largescale biologics facility that will produce monoclonal antibodies by 2020 Features The companies will build and operate a largescale mammalian cell culture facility for monoclonal antibody production in Visp, Switzerland The...
